Carboxymethylated chitin reduces MMP-1 expression in rabbit ACLT osteoarthritic cartilage

Annals of the Rheumatic Diseases

Volumn 63, Issue 4, 2004, Pages 369-372

  Hongbin, W ^a   Jingyuan, D ^a   Linyun, C ^b   Yuming, D ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYL GROUP; CARBOXYMETHYLCHITIN; CHITIN; INTERSTITIAL COLLAGENASE; MESSENGER RNA; METHYL GROUP; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ANTERIOR CRUCIATE LIGAMENT TRANSECTION; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMUR CONDYLE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIGAMENT SURGERY; MICROSCOPY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; CARTILAGE, ARTICULAR; CHITIN; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRA-ARTICULAR; MATRIX METALLOPROTEINASE 1; OSTEOARTHRITIS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 1842453335     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2002.001461     Document Type: Article

References (22)

1. Malemud O, Goldberg VM. Future directions for research and treatment of osteoarthritis. Front Biosci 1999;4:D762-71.
2. Huebner JL, Otterness IG, Freund EM, Caterson B, Kraus VB. Collagenase 1 and collagenase 3 expression in a guinea pig model of osteoarthritis. Arthritis Rheum 1998;41:877-90.
3. Klein R, Becker EW, Berg PA, Bernau A. Immunomodulatory properties of rumalon, a glycosaminoglycan peptide complex, in patients with osteoarthritis: activation of T helper cell type 2 cytokines and antigen-specific IgG4 antibodies. J Rheumatol 2000;27:448-54.
4. Deal CL, Moskowitz RW. Neutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999;25:379-95.
5. Takahashi K, Hashimoto S, Kubo T, Hirasawa Y, Lotz M, Amiel D. Effect of hyanuronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 2000;27:1713-20.
6. Sechriest VF, Miao YJ, Niyibizi C, Westerhausen-Larsan A, Matthew HW, Evans CH, et al. GAG-augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis. J Biomed Mater Res 2000;49:534-41.
7. Suh JK, Matthew HW. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 2000;21(24):2589-98.
8. Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41:1275-86.
9. Mankin HJ, Dorfman H, Lippiello L, Zarins A. J Bone Joint Surg Am 1971;53:523-37.
10. Pelletier JP, Lascau-Coman V, Jovanovic D, Fernandes JC, Manning P, Connor JR, et al. Selective inhibition of inducible nitric oxide synthase in experimental oateoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 1999;26:2002-14.
11. Han F, Ishiguro N, Ito T, Sakai T, Iwata H. Effects of sodium hyaluronate on experimental osteoarthritis in rabbit knee joints. Nagoya J Med Sci 1999;62:115-26.
12. Lu JX, Prudhommeaux F, Meunier A, Sedel L, Guillemin G. Effects of chitosan on rat knee cartiloges. Biomaterials 1999;20:1937-44.
13. Hwang SM, Chen CY, Chen SS, Chen JC. Chitinous materials inhibit nitric oxide production by activated RAW 264.7 macrophages. Biochem Biophys Res Commun 2000;27:229-33.
14. Hashimoto S, Tokahashi K, Amiel D, Coutts RD, Lotz M. Chondrocyte apoptosis and nitic oxide production during experimental induced osteoarthritis. Arthritis Rheum 1998;41:1266-74.
15. Muzzarelli RAA. Carboxymethylated chitins and chitosans. Carbohydrate Polymers 1988;8:1-21.
16. Brandt KD, Braunstein EM, Visco DM, O'Connor B, Heck D, Albrecht M. Anterior (cranial) cruciate ligament transection in the dog: a bona fide model of osteoarthritis, not merely of cartilage injury and repair. J Rheumatol 1991;18:436-46.
17. Tetlaw LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001;44:585-94.
18. Ishiguro N, Ito T, Ito H, Iwata H, Jugessur H, Ionescu M, et al. Relationship of matrix metalloproteinoses and their inhibitors to cartilage proteoglycan and collagen turnover: analysis of synovial fluid from patients with osteoarthritis. Arthritis Rheum 1999;42:129-36.
19. Hallander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II in aging and osteoarthritis starts at the articular surface, originates round chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995;96:2859-69.
20. Jin G, Sah RL, Li YS, Shyy JY, Chien S. Biomechanical regulation of matrix metalloproteinase-9 in cultured chondrocytes. J Orthop Res 2000;18:899-908.
21. Pelletier JP, Faure MP, DiBattista JA, Wilhelm S, Visco D, Martel-Pelletier J. Coordinate synthesis of stromylisine, interleukin-1 and oncogene proteins in experimental osteoarthritis. An immunohistochemical study. Am J Pathol 1993;142:95-105.
22. Lahiji A, Sohrabi A, Hungerford DS, Frondoza CG. Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res 2000;51:586-95.